Editing Cannabinoid (section)

==== ''N''-Arachidonoyl dopamine (NADA) ====
{{Main|N-Arachidonoyl dopamine|l1=''N''-Arachidonoyl dopamine}}
Discovered in 2000, NADA preferentially binds to the CB<sub>1</sub> receptor.<ref>{{cite journal | vauthors = Bisogno T, Melck D, Gretskaya NM, Bezuglov VV, De Petrocellis L, Di Marzo V | title = N-acyl-dopamines: novel synthetic CB(1) cannabinoid-receptor ligands and inhibitors of anandamide inactivation with cannabimimetic activity in vitro and in vivo | journal = The Biochemical Journal | volume = 351 Pt 3 | issue = 3 | pages = 817–824 | date = November 2000 | pmid = 11042139 | pmc = 1221424 | doi = 10.1042/bj3510817 }}</ref> Like anandamide, NADA is also an agonist for the [[TRPV1|vanilloid receptor subtype 1]] (TRPV1), a member of the [[vanilloid]] receptor family.<ref name="Bisogno 2005">{{cite journal | vauthors = Bisogno T, Ligresti A, Di Marzo V | title = The endocannabinoid signalling system: biochemical aspects | journal = Pharmacology, Biochemistry, and Behavior | volume = 81 | issue = 2 | pages = 224–238 | date = June 2005 | pmid = 15935454 | doi = 10.1016/j.pbb.2005.01.027 | s2cid = 14186359 }}</ref><ref>{{cite journal | vauthors = Ralevic V | title = Cannabinoid modulation of peripheral autonomic and sensory neurotransmission | journal = European Journal of Pharmacology | volume = 472 | issue = 1–2 | pages = 1–21 | date = July 2003 | pmid = 12860468 | doi = 10.1016/S0014-2999(03)01813-2 }}</ref>